References
- 1. J. A. Yáñez, P. K. Andrews and N. M. Davies, Methods of analysis and separation of chiral flavonoids, J. Chromatogr. B848 (2007) 159–181; https://doi.org/10.1016/j.jchromb.2006.10.052
- 2. J. Xiao and P. Högger, Metabolism of dietary flavonoids in liver microsomes, Curr. Drug Metab.14 (2013) 381–391; https://doi.org/10.2174/1389200211314040003
- 3. B. H. Havsteen, The biochemistry and medical significance of the flavonoids, Pharmacol. Therapeut. 96 (2002) 67–202; https://doi.org/10.1016/S0163-7258(02)00298-X
- 4. J. Viskupičová, M. Ondrejovič and E. Šturdík, Bioavailability and metabolism of flavonoids, J. Food Nutr. Res.47 (2008) 151–162.
- 5. F. P. Guengerich, Cytochrome P450 and chemical toxicology, Chem. Res. Toxicol.21 (2008) 70–83; https://doi.org/10.1021/tx700079z
- 6. V. P. Androutsopoulos, A. Papakyriakou, D. Vourloumis and D. A. Spandidos, Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids, Bioorg. Med. Chem.19 (2011) 2842–2849; https://doi.org/10.1016/j.bmc.2011.03.042
- 7. S. E. Nielsen, V. Breinholt, U. Justesen, C. Cornett and L. O. Dragsted, In vitro biotransformation of flavonoids by rat liver microsomes, Xenobiotica28 (1998) 389–401; https://doi.org/10.1080/004982598239498
- 8. V. M. Breinholt, E. A. Offord, C. Brouwer, S. E. Nielsen, K. Brøsen and T. Friedberg, In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids, Food Chem. Toxicol.40 (2002) 609–616; https://doi.org/10.1016/S0278-6915(01)00125-9
- 9. A. Gradolatto, M. C. Canivenc-Lavier, J. P. Basly, M. H. Siess and C. Teyssier, Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver, Drug Metab. Dispos.32 (2004) 58–65; https://doi.org/10.1124/dmd.32.1.58
- 10. V. Androutsopoulos, N. Wilsher, R. R. J. Arroo and G. A. Potter, Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450, Cancer Lett.274 (2009) 54–60; https://doi.org/10.1016/j.canlet.2008.08.032
- 11. S. E. Nielsen, V. Breinholt, C. Cornett and L. O. Dragsted, Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus, Food Chem. Toxicol.38 (2000) 739–746; https://doi.org/10.1016/S0278-6915(00)00072-7
- 12. V. M. Breinholt, S. E. Rasmussen, K. Brøsen and T. H. Friedberg, In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s, Pharmacol. Toxicol.93 (2003) 14–22; https://doi.org/10.1034/j.1600-0773.2003.930102.x
- 13. Y. Otake and T. Walle, Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2 and CYP2C9, Drug Metab. Dispos.30 (2002) 103–105; https://doi.org/10.1124/dmd.30.2.103
- 14. S. E. Kulling, D. M. Honig and M. Metzler, Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo, J. Agric. Food Chem. 49 (2001) 3024–3033; https://doi.org/10.1021/jf0012695
- 15. S. E. Kulling, D. M. Honig, T. J. Simat and M. Metzler, Oxidative in vitro metabolism of the soy phytoestrogens daidzein and genistein, J. Agric. Food Chem.48 (2000) 4963–4972; https://doi.org/10.1021/jf000524i
- 16. S. E. Kulling, L. Lehmann and M. Metzler, Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens, J. Chromatogr. B777 (2002) 211–218; https://doi.org/10.1016/S1570-0232(02)00215-5
- 17. M. Hu, K. Krausz, J. Chen, X. Ge, J. Li, H. L. Gelboin and F. J. Gonzalez, Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones, Drug Metab. Dispos.31 (2003) 924–931; https://doi.org/10.1124/dmd.31.7.924
- 18. J. Bursztyka, E. Perdu, J. Tulliez, L. Debrauwer, G. Delous, C. Canlet, G. De Sousa, R. Rahmani, E. Benfenati and J. P. Cravedi, Comparison of genistein metabolism in rats and humans using liver microsomes and hepatocytes, Food Chem. Toxicol.46 (2008) 939–948; https://doi.org/10.1016/j.fct.2007.10.023
- 19. K. M. Atherton, E. Mutch and D. Ford, Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity, Biochem. Pharmacol.72 (2006) 624–631; https://doi.org/10.1016/j.bcp.2006.05.015
- 20. H. Doostdar, M. D. Burke and R. T. Mayer, Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1, Toxicology144 (2000) 31–38; https://doi.org/10.1016/S0300-483X(99)00215-2
- 21. J. M. Young, W. Xiaodong and E. M. Marilyn, Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism, Toxicol. In Vitro20 (2006) 187–210; https://doi.org/10.1016/j.tiv.2005.06.048
- 22. Y. Kimura, H. Ito, R. Ohnishi and T. Hatano, Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity, Food Chem. Toxicol.48 (2010) 429–435; https://doi.org/10.1016/j.fct.2009.10.041
- 23. M. Bojić, C. A. Sedgeman, L. D. Nagy and F. P. Guengerich, Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450, Eur. J. Pharm. Sci.73 (2015) 49–56; https://doi.org/10.1016/j.ejps.2015.03.015
- 24. M. Medić-Šarić, V. Rastija and M. Bojić, Recent advances in the application of high performance liquid chromatography in the analysis of polyphenols in wine and propolis, J. AOAC Int.94 (2011) 32–42.
- 25. M. Barbarić, K. Mišković, M. Bojić, M. Baus Lončar, A. Smolčić-Bubalo, Ž. Debeljak and M. Medić-Šarić, Chemical composition of the ethanolic propolis extracts and its effect on HeLa cells, J. Ethnopharmacol.135 (2011) 772–778; https://doi.org/10.1016/j.jep.2011.04.015
- 26. D. Tsimogiannis, M. Samiotaki, G. Panayotou and V. Oreopoulou, Characterization of flavonoid subgroups and hydroxy substitution by HPLC-MS/MS, Molecules12 (2007) 593–606; https://doi.org/10.3390/12030593
- 27. F. Cuyckens and M. Claeys, Mass spectrometry in the structural analysis of flavonoids, J. Mass Spectrom.39 (2004) 1–15; https://doi.org/10.1002/jms.585
- 28. F. P. Guengerich, Human Cytochrome P450 Enzymes, in Cytochrome P450: Structure, Mechanism, and Biochemistry (Ed. P. R. Ortiz de Montellano), 4th ed., Springer Int. Publ. Switzerland, Cambridge 2015; https://doi.org/10.1007/978-3-319-12108-6_9
- 29. V. P. Androutsopoulos, S. Mahale, R. R. J. Arroo and G. Potter, Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation, Oncol. Rep.21 (2009) 1525–1528; https://doi.org/10.3892/or_00000384